3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Lung Neoplasms
3
Colorectal Neoplasms
3
Lymphoma
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Quality of Life
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Paranasal Sinus Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mouth Neoplasms
1
Mixed Dementias
1
Mesothelioma, Malignant
1
Meningeal Carcinomatosis
1
Maxillary Sinus Neoplasms
1
Lymphoma, Follicular
1
Lewy Body Disease
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Interventions
Oxaliplatin
5
Mitomycin
3
Irinotecan
3
Hyperthermic Intraperitoneal Chemotherapy
3
Capecitabine
3
Trastuzumab
2
Thalidomide
2
Leucovorin
2
Interleukin-12 Subunit p35
2
Cisplatin
2
tipifarnib
1
nilotinib
1
entinostat
1
durvalumab
1
Yoga
1
Watchful Waiting
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Referral and Consultation
1
Quality of Life
1
Psychiatric Rehabilitation
1
Pharmacogenomic Testing
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Ondansetron
1
Molecular Diagnostic Techniques
1
Melphalan
1
Laparoscopy
1
Interleukin-12
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Appendiceal Neoplasms
×
Referral and Consultation
×
Clear all
NCT01126346
2018-07-03
HOPE
Wake Forest University Health Sciences
Phase NA
Completed
10 enrolled